Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period
Kadowaki, Takashi, Kondo, Kazuoki, Sasaki, Noriyuki, Miyayama, Kyoko, Yokota, Shoko, Terata, Ryuji, Gouda, MakiVolume:
18
Language:
english
Journal:
Expert Opinion on Pharmacotherapy
DOI:
10.1080/14656566.2017.1359259
Date:
September, 2017
File:
PDF, 1.23 MB
english, 2017